1. Home
  2. BLKB vs FTRE Comparison

BLKB vs FTRE Comparison

Compare BLKB & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackbaud Inc.

BLKB

Blackbaud Inc.

HOLD

Current Price

$31.38

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$17.86

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLKB
FTRE
Founded
1981
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
2004
2023

Fundamental Metrics

Financial Performance
Metric
BLKB
FTRE
Price
$31.38
$17.86
Analyst Decision
Hold
Buy
Analyst Count
3
9
Target Price
$50.00
$14.06
AVG Volume (30 Days)
842.1K
1.4M
Earning Date
04-29-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
142.32
N/A
EPS
0.67
N/A
Revenue
N/A
$2,723,400,000.00
Revenue This Year
$6.26
N/A
Revenue Next Year
$4.25
$3.09
P/E Ratio
$47.04
N/A
Revenue Growth
N/A
1.00
52 Week Low
$25.58
$4.46
52 Week High
$74.86
$18.67

Technical Indicators

Market Signals
Indicator
BLKB
FTRE
Relative Strength Index (RSI) 57.91 59.62
Support Level $28.88 $15.40
Resistance Level $32.11 $18.13
Average True Range (ATR) 1.45 0.88
MACD 0.41 -0.06
Stochastic Oscillator 88.73 67.12

Price Performance

Historical Comparison
BLKB
FTRE

About BLKB Blackbaud Inc.

Founded in 1981, Blackbaud provides software solutions designed to serve the "social good" community, including nonprofits, foundations, corporations, educational institutions, healthcare institutions, and individual change agents. Through M&A and organic product development efforts, the company has also moved into related areas outside core fundraising, notably into K-12 schools. The firm enables more than $100 billion in donations annually across a customer base in excess of 40,000 customers in over 100 countries.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.

Share on Social Networks: